[{"id":"1a71cc73-8c30-4b21-b6fd-04a86ca5ef3f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05341557","created_at":"2022-04-22T13:53:35.938Z","updated_at":"2024-07-02T16:36:08.581Z","phase":"Phase 1","brief_title":"A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma","source_id_and_acronym":"NCT05341557","lead_sponsor":"Betta Pharmaceuticals Co., Ltd.","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BPI-371153"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 110","initiation":"Initiation: 06/01/2022","start_date":" 06/01/2022","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2022-06-20"}]